LC-MS/MS raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
| Property | Value | Notes |
|---|---|---|
| Primary target | PPARδ (NR1C2) | Nuclear receptor involved in lipid metabolism |
| Preclinical effect | Increased fatty acid oxidation | Observed in rodent studies |
| Key safety signal | Tumors in rodents after long-term exposure | Contributed to halted clinical development |
| Human trial status | No approved product; development stopped | Limited short-term metabolic data |
| Sport regulatory status | Prohibited at all times | WADA hormone and metabolic modulators class |
Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.
Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.
Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.
Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.
The family's first home in exile was Wartegg Castle in Rorschach, Switzerland, a property owned by the Bourbon-Parmas. However, the Swiss authorities, worried about the implications of the Habsburgs living near the Austrian border, compelled them to move to the western part of the country. The next month, the Habsburgs moved to Villa Prangins, near Lake Geneva, where they resumed a quiet family life. This abruptly ended in March 1920 when, after a period of instability in Hungary, Miklós Horthy was elected regent. Charles was still technically King (as Charles IV) but Horthy sent an emissary to Prangins advising him not to go to Hungary until the situation had calmed. After the Trianon Treaty Horthy's ambition soon grew. Charles became concerned and requested the help of Colonel Strutt to get him into Hungary. Charles twice attempted to regain control, once in March 1921 and again in October 1921. Both attempts failed, despite Zita's staunch support (she insisted on travelling with him on the final dramatic train journey to Budapest). Charles and Zita temporarily resided at Tata Castle, the home of Count Esterházy, until a suitable permanent exile could be found. Malta was mooted as a possibility, but was declined by Lord Curzon, and French territory was ruled out given the possibility of Zita's brothers intriguing on Charles's behalf. Eventually, the Portuguese island of Madeira was chosen. On 31 October 1921, the former Imperial couple were taken by rail from Tihany to Baja, where the Royal Navy monitor HMS Glowworm was waiting.
== Production and use == Nitrilotriacetic acid is commercially available as the free acid and as the sodium salt. It is produced from ammonia, formaldehyde, and sodium cyanide or hydrogen cyanide. NTA is also cogenerated as an impurity in the synthesis of EDTA, arising from reactions of the ammonia coproduct. Older routes to NTA included alkylation of ammonia with chloroacetic acid and oxidation of triethanolamine.
Further reading Granger, JP; Alexander, BT; Llinas, M (2002). "Mechanisms of pressure natriuresis". Current Hypertension Reports. 4 (2): 152–9. doi:10.1007/s11906-002-0040-3. PMID 11884271. S2CID 46323264. Hall, J. E.; Mizelle, H. L.; Hildebrandt, D. A.; Brands, M. W. (1990). "Abnormal pressure natriuresis. A cause or a consequence of hypertension?". Hypertension. 15 (6_Pt_1): 547–59. doi:10.1161/01.HYP.15.6.547. PMID 1971810.
In 1974, a military coup overthrew the Estado Novo regime, and started the Carnation Revolution. This initiated the transition to democracy and the dissolution of Portugal's colonial empire, from the independence of the African colonies to the Handover of Macau in 1999. This period was marked by social, military, and political turmoil that culminated in street politics and violence and led Portugal to near civil war. The 1975 coup cleared the way for the approval of a new constitution and the holding of elections, beginning to subside tensions. After the revolution, in the late 1970s and throughout the 1980s, under the influence of new economic insights, Portugal set about dismantling socialist policies from that period and moving towards neoliberalism. In 1986, Portugal joined the European Economic Community (EEC), which introduced structural reforms. This led in the 1990s to considerable economic growth driven by credit-fuelled consumer spending and a sharp rise in private indebtedness. Together with the growth of the financial and non-tradable sectors, this contributed to macroeconomic imbalances and paved the way for economic stagnation after the 2000s. It ultimately led to the 2010–2014 Portuguese financial crisis resulted in an international bailout and intense austerity policies, causing lasting impacts such as young adults' employment insecurity.
Sources: en.wikipedia.org
double-stranded DNA (dsDNA) Any DNA molecule that is composed of two antiparallel, complementary deoxyribonucleotide polymers, known as strands, which are bonded together by hydrogen bonds between the complementary nucleobases. Though it is possible for DNA to exist as a single strand, it is generally more stable and more common in double-stranded form. In most cases, the complementary base pairing causes the twin strands to coil around each other in the shape of a double helix.
"H" stands for "high metal" because CH chondrites may contain up to as much as 40% of metal. That makes them one of the most metal-rich of any of the chondrite groups, second only to the CB chondrites and some ungrouped chondrites such as NWA 12273. The first meteorite discovered was ALH 85085. Chemically, these chondrites are closely related to CR and CB groups. All specimens of this group belong only to petrologic types 2 or 3.
== Career == In 1847, at age 21, he joined his father's banking firm, Beckett & Co. He later became a partner and, in 1874, was made head of the firm at Leeds, Doncaster, and Retford. Upon the retirement of Leslie Melville, he became head of the English County Bankers' Association as well as the East Riding Bank at Beverley and Malton. He was a captain in the Yorkshire Hussar Yeomanry Cavalry and a J.P. and Deputy Lieutenant for the West Riding of Yorkshire. In 1865, Beckett became the first chairman of the publishing company, Yorkshire Post Newspapers. Successive chairmen were members of the Beckett family until the retirement of Rupert Beckett in 1950. In 1876, Beckett was elected a Conservative Member of Parliament for East Retford but lost the seat in 1880. At the 1885 general election, he was elected MP for Bassetlaw. He held the seat until his death in 1890.
Sources: en.wikipedia.org
Rodent studies reported increased endurance and fat oxidation after GW501516 exposure. Long-term studies also found higher rates of some tumors, which led to halted development.
Small short-term human trials examined metabolic markers such as lipids and glucose. The trials did not continue after rodent cancer findings, so long-term human safety is unknown.
Controlled human trials have not established a performance benefit. Anecdotal reports exist, but they are not reliable evidence.
Legal status varies by country, but cardarine is not approved as a medicine in major jurisdictions. It is often sold as a research chemical, a category that may not be lawful for human use. Buyers should check local laws and product labels carefully.